Researchers Tushar Nichakawade (left), Suman Paul (middle) and Jiaxin Ge (right) in the lab. Credit: Johns Hopkins Kimmel Cancer Center. A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective at killing these cancers in mice bearing human T-cell tumors.

https://www.hopkinsmedicine.org/news/newsroom/news-releases/2024/04/johns-hopkins-investigators-develop-novel-treatment-for-t-cell-leukemias-and-lymphomas